Testing effectiveness (Phase 2)Study completedNCT04107103What this trial is testingNivolumab Plus Pemetrexed for Head and Neck Squamous Cell CarcinomaWho this might be right forSCCHN AHS Cancer Control Alberta 6
Large-scale testing (Phase 3)Looking for participantsNCT06235203What this trial is testingNeoadjuvant vs Adjuvant in Locally Advanced Recurrent NPCWho this might be right forRecurrent Nasopharyngeal Carcinoma Eye & ENT Hospital of Fudan University 154
Large-scale testing (Phase 3)Looking for participantsNCT06927986What this trial is testingPhase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）Who this might be right forEGFR-mutated Locally Advanced or Metastatic NSCLC CSPC Megalith Biopharmaceutical Co.,Ltd. 380
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more Exelixis 1,314
Testing effectiveness (Phase 2)Looking for participantsNCT06470217What this trial is testingTirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell CarcinomaWho this might be right forLocally Advanced Head and Neck Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 116
Early research (Phase 1)UnknownNCT03282617What this trial is testingDendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Cancer National University Hospital, Singapore 55
Early research (Phase 1)WithdrawnNCT02105350What this trial is testingMEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWho this might be right forBiliary Tract CarcinomaGallbladder Carcinoma University Health Network, Toronto
Testing effectiveness (Phase 2)Looking for participantsNCT06728410What this trial is testingA Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or RearrangementWho this might be right forIntrahepatic CholangiocarcinomaFGFR2 Gene RearrangementFGFR2 Gene Mutation Mehmet Akce 38
Testing effectiveness (Phase 2)Study completedNCT03665285What this trial is testingA Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more NextCure, Inc. 109
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07360743What this trial is testingImmunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 LevelsWho this might be right forNon Small Cell Lung Cancer (Squamous or Non Squamous) UNICANCER 275
Large-scale testing (Phase 3)Study completedNCT00390455What this trial is testingFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveWho this might be right forEstrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)Study completedNCT00274443What this trial is testingAn Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With CarboplatinWho this might be right forNon-Small Cell Lung Cancer (NSCLC) Celgene 250
Testing effectiveness (Phase 2)Study completedNCT00602797What this trial is testingVinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung CancerWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer University of Nebraska 20
Testing effectiveness (Phase 2)Looking for participantsNCT05652920What this trial is testingOri-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCCWho this might be right forHepatocellular Carcinoma OriCell Therapeutics Co., Ltd. 105
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center
Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Early research (Phase 1)Ended earlyNCT01187615What this trial is testingDetermination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung CancerWho this might be right forSmall Cell Lung Carcinoma Bayer 9
Early research (Phase 1)Ended earlyNCT06420349What this trial is testingNXP800 for the Treatment of Patients With Advanced or Metastatic CholangiocarcinomaWho this might be right forAdvanced CholangiocarcinomaMetastatic CholangiocarcinomaRefractory Cholangiocarcinoma+4 more Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT03685448What this trial is testingANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)Who this might be right forRenal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Early research (Phase 1)Looking for participantsNCT06374485What this trial is testingStudy of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard TreatmentWho this might be right forAdvanced Hepatocellular Carcinoma Lee's Pharmaceutical Limited 18